Parametric Portfolio Associates’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
TS
MVP
IAM
Parametric Portfolio Associates's PGEN Position: Q1 2022 in Review
Parametric Portfolio Associates increased its Precigen (PGEN) stake by 32% in Q1 2022, buying an estimated $40K and bringing the position to 68,600 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #3503.
Parametric Portfolio Associates first reported a position in PGEN in Q3 2015 and has held it in 25 quarters since. The position peaked at $3.1M in Q2 2016. 173 funds tracked by Wall St. Rank hold PGEN as of Q1 2022.
- Parametric Portfolio Associates held 68,600 shares of Precigen worth $145K as of Q1 2022.
- Parametric Portfolio Associates bought 16,433 Precigen shares in Q1 2022, an estimated $40K.
- Precigen made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3503 holding.
- Parametric Portfolio Associates first reported a position in Precigen in Q3 2015 and has held it in 25 quarters since.
- Parametric Portfolio Associates's Precigen position peaked at $3.1M in Q2 2016.
- 173 funds tracked by Wall St. Rank held Precigen as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.